Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- Check4 days agoChange DetectedA new revision line, Revision: v3.5.3, appears in the Record History. It supersedes the previous Revision: v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe record history now includes a new revision entry (v3.5.2) and removes the previous revision (v3.5.0).SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded revision v3.4.2 to the study record history; removed the government funding lapse notice (v3.4.1).SummaryDifference0.7%

- Check90 days agoChange DetectedA site-wide Notice about funding-related data delays was added, and a new revision entry (v3.4.1) was introduced in the history.SummaryDifference0.7%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.